Perspective · 20 Dec 2024
Conference abstractPublished 2017
A metabolomics approach for therapy response in breast cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Due to its broad clinical heterogeneity, the treatment of breast cancer is based on a wide variety of protocols. However, only a fraction of patients will show a beneficial response. The discovery of biomarkers which enable the classification of responders and non-responders patients may have important implications to treatment protocols and outcomes. In this study, we carried out a metabolomic profiling of 46 serum samples of breast cancer patients at diagnostic to identify potential biomarker candidates that can predict response to neoadjuvant chemotherapy. To this end, we analyzed the samples using liquid chromatography couple to high resolution mass spectrometry LC-HRMS and the data matrix obtained was subjected to univariate and multivariate statistical analysis.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Archives in Cancer Research.
Perspective · 20 Dec 2024
Chemotherapy: A Vital Treatment in the Battle Against Cancer
Perspective · 20 Dec 2024
Tumor Microenvironment: A Key Determinant of Cancer Progression
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives in Cancer Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Pedro Sanchez Rovira”
